RECURRENT GLIOBLASTOMA

Clinical trials for RECURRENT GLIOBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT GLIOBLASTOMA trials appear

Sign up with your email to follow new studies for RECURRENT GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 22 Not yet recruiting 3 Not yet finished but already full! 14 Completed 5 Terminated 1

Scientists test new pill to fight deadly brain tumors

Disease control Terminated

This early-stage study tested a new oral drug called navtemadlin (AMG 232) for glioblastoma, a fast-growing brain cancer. The trial had two parts: first, to see if the drug could reach brain tumor tissue in patients whose cancer had returned; second, to find a safe dose to combin…

Matched conditions: RECURRENT GLIOBLASTOMA

Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 31, 2026 12:11 UTC

RECURRENT GLIOBLASTOMA

Get alerted when new RECURRENT GLIOBLASTOMA trials appear

Scientists test new pill to fight deadly brain tumors